Bausch Health Companies Raises FY2026 Sales Guidance from $10.625B-$10.875B to $10.670B-$10.920B vs $10.678B Est

Benzinga Newsdesk www.benzinga.com Positive 92.9%

Neg 0% Neu 0% Pos 92.9%

Bausch Health Companies (TSX:BHC) raises FY2026 sales outlook from $10.625 billion-$10.875 billion to $10.670 billion-$10.920 billion vs $10.678 billion estimate.